Internal Medicine, Hematology & Oncology · Maplewood, MN
NPI
1790723328
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1580 Beam Ave
Maplewood, MN, 55109
Phone (651) 779-7978
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.4M
234,490 services
Medicare patients, 2024
624
Average age 75
Drug cost, 2024
$20.2M
4,047 prescriptions
Company payments, 2025
$14.2
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vladimir Hugec was code J9171 (injection, docetaxel, 1 mg), 20,679 times for 68 patients. In total Vladimir Hugec billed 234,490 services in 180 codes, and Medicare paid $4.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-11-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9171 Injection, docetaxel, 1 mg | Office | 20,679 | 68 | $0.69 | $14K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 20,300 | 39 | $43.05 | $874K |
| J0185 Injection, aprepitant, 1 mg | Office | 18,980 | 69 | $1.34 | $25K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 12,900 | 18 | $2.31 | $30K |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 11,730 | 13 | $0.27 | $3,213 |
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 8,580 | 11 | $0.22 | $1,884 |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 8,140 | 13 | $0.05 | $433 |
| J9267 Injection, paclitaxel, 1 mg | Office | 7,014 | 15 | $0.08 | $555 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 5,502 | 53 | $0.10 | $523 |
| Q5118 Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | Office | 4,430 | 12 | $17.01 | $75K |
| J0897 Injection, denosumab, 1 mg | Office | 4,140 | 26 | $20.68 | $86K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 2,446 | 48 | $0.23 | $555 |
| J9043 Injection, cabazitaxel, 1 mg | Office | 2,280 | 18 | $167.62 | $382K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,790 | 81 | $0.71 | $1,266 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,770 | 78 | $0.25 | $440 |
By year: 2022 $3.2M for 186,107 services; 2023 $3.3M for 207,899 services; 2024 $4.4M for 234,490 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,416 | 427 | $7.60 | $11K |
| 80053 Clinical Chemistry | 1,307 | 427 | $10.34 | $14K |
| 36415 Venipuncture Blood Collection | 1,246 | 390 | $8.63 | $11K |
| 83550 Clinical Chemistry | 1,086 | 381 | $8.56 | $9,301 |
| 83540 Clinical Chemistry | 1,086 | 381 | $6.34 | $6,880 |
| 82728 Clinical Chemistry | 1,048 | 376 | $13.35 | $14K |
| 84153 Clinical Chemistry | 691 | 222 | $18.02 | $12K |
| 82378 Clinical Chemistry | 633 | 233 | $18.58 | $12K |
| 82784 Immunoassay | 444 | 77 | $9.11 | $4,046 |
| 83615 Clinical Chemistry | 285 | 198 | $5.92 | $1,687 |
Medicare prescription drug claims, 2024
In 2024, the drug Vladimir Hugec prescribed most often to Medicare patients was Nubeqa (Darolutamide), with 767 prescriptions and refills. In total Vladimir Hugec wrote 4,047 Medicare prescriptions that cost $20.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Nubeqa Darolutamide | 767 | 770 | 102 | $9.9M |
| Dexamethasone Generic | 431 | 432 | 130 | $3,897 |
| Prednisone Generic | 356 | 406 | 74 | $1,697 |
| Abiraterone Acetate Generic | 294 | 296 | 48 | $295K |
| Xtandi Enzalutamide | 172 | 172 | 27 | $1.9M |
| Levothyroxine Sodium Generic | 150 | 311 | 39 | $1,897 |
| Lynparza Olaparib | 143 | 143 | 28 | $2.1M |
| Acyclovir Generic | 114 | 167 | 19 | $2,144 |
| Olanzapine Generic | 100 | 110 | 62 | $703 |
| Furosemide Generic | 87 | 88 | 34 | $226 |
| Eliquis Apixaban | 73 | 91 | 15 | $51K |
| Allopurinol Generic | 71 | 145 | 21 | $854 |
| Anastrozole Generic | 64 | 149 | 16 | $1,612 |
| Famotidine Generic | 62 | 98 | 27 | $580 |
| Prochlorperazine Maleate Generic | 59 | 59 | 48 | $761 |
Brand drugs: 1,728 claims; generic drugs: 2,319 claims; opioid claims: 55.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vladimir Hugec $14.2 ($14.2 in general payments such as food, travel and fees) from 1 company. The largest payer was Janssen Biotech, Inc. with $14.2.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 1 | $14.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.